INmune Bio (INMB): Today’s Developments and Future Prospects
INmune Bio, Inc. (NASDAQ: INMB) is a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease. The company’s pipeline includes therapies targeting various diseases, including cancer and Alzheimer’s disease. Today, INmune Bio…